Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study

Camostat mesylate is expected to be promising as a treatment option for COVID-19, in addition to other indications for which it is currently used. Furthermore, in vitro experiments have confirmed the potential of camostat and its metabolites to be effective against COVID-19. Therefore, clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gwanyoung, Moon, Hyun-ki, Kim, Taeheon, Yun, So-hye, Yun, Hwi-yeol, Hong, Jang Hee, Kim, Dae-Duk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534584/
https://www.ncbi.nlm.nih.gov/pubmed/37765325
http://dx.doi.org/10.3390/pharmaceutics15092357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534584/
https://www.ncbi.nlm.nih.gov/pubmed/37765325
http://dx.doi.org/10.3390/pharmaceutics15092357

Ejemplares similares